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OBJECTIVE — Weight loss among metabolically healthy obese (MHO) individuals may be
unnecessary or result in elevated cardio-metabolic risk. We studied the effects of exercise- or
diet-induced weight loss on cardio-metabolic risk among MHO and metabolically abnormal
obese (MAO) adults.
RESEARCH DESIGN AND METHODS — Participants were 63 MHO and 43 MAO
adults who took part in 3 to 6 months of exercise- or diet-induced weight loss intervention.
Changes in anthropometry, adipose tissue distribution, and cardio-metabolic risk factors were
assessed.
RESULTS — Body weight, waist circumference, and total abdominal and visceral adipose
tissuewerereducedinallsubjects(P0.05).Improvementsininsulinsensitivitywereobserved
in MHO and MAO men and women (P  0.05), but were greater in the MAO individuals (P 
0.05). Fasting insulin was the only other cardio-metabolic improvement among MHO individ-
uals (P  0.05).
CONCLUSIONS — Lifestyle-induced weight loss among MHO subjects is associated with a
reduction in total and abdominal obesity and improvement in selected cardio-metabolic risk
factors.
Diabetes Care 33:1957–1959, 2010
W
eight loss among metabolically
healthy obese (MHO) individu-
als characterized by low cardio-
metabolicriskandlowprospectiveriskof
type2diabetesandcardiovasculardisease
may be unnecessary and paradoxically
may actually increase health risk (1,2).
Thatweightreductionmaybecontraindi-
catedforMHOindividualsisatoddswith
the standing recommendation from lead-
ing health authorities that weight loss be
the primary treatment strategy for all
obese patients, regardless of cardio-
metabolic status (3). We sought to inves-
tigate the effects of exercise- and diet-
induced weight reduction on cardio-
metabolic risk factors among MHO and
metabolically abnormal obese (MAO)
adults.
RESEARCH DESIGN AND
METHODS— Subjects included Cau-
casian men and premenopausal and post-
menopausal women without overt
disease who were recruited from the gen-
eral public and had participated in previ-
ously published lifestyle-based weight
loss studies (4–6). For the current inves-
tigation, we employed data from men
(n  20) and women (n  29) random-
ized to either the diet-induced or the ex-
ercise-induced weight loss intervention
(4,5). Additionally, 136 older abdomi-
nallyobesemenandwomen(aged60–80
years) participated in a study on the ef-
fects of resistance and/or aerobic exercise
on risk factors for disease and disability
(6). For the current investigation, data
from those men (n  26) and women
(n  34) randomized to the aerobic exer-
cise or the resistance and aerobic exercise
combined group were included. All par-
ticipants gave informed consent in accor-
dance with the ethical guidelines set by
Queen’s University.
Deﬁnition of MHO versus MAO
We deﬁned MHO men and women as ab-
dominally obese (waist circumference
88 cm in women and 102 cm in men)
with one or none of the following risk
factors: fasting plasma glucose 5.6
mmol/l, triglycerides 1.7 mmol/l, HDL
cholesterol 1.0 mmol/l in men and
1.3 mmol/l in women, and blood pres-
sure130/85mmHg(7).Allparticipants
meeting two or more of the above risk
factors were classiﬁed as MAO. Although
we deﬁned the MHO and MAO groups
according to a clustering of cardio-
metabolic risk factors, our primary obser-
vationsregardingimprovementininsulin
sensitivity remained when subjects were
categorized solely by tertiles of insulin
sensitivity at baseline (these data can
be found in supplementary Fig. 1,
available in an online appendix at
http://care.diabetesjournals.org/cgi/
content/full/dc10-0547/DC1).
Interventions
Of the 46 men in the current study, 20
wererandomlyassignedtoadiet(n11)
or exercise (n  9) program designed to
induce a daily 700-kcal energy deﬁcit for
12 weeks (4). The remaining men were
randomized to either 6 months of aerobic
exercise (n  13) performed 5 times per
week for 30 min or to resistance and aer-
obic exercise combined (n  13) per-
formed 3 times per week (30 min of
aerobic exercise plus 20 min of resis-
tance exercise per session) (6).
Of the 63 women in the current
study, 29 premenopausal women were
randomized to a diet (n  13) or exercise
(n  16) program designed to induce a
daily500-kcalenergydeﬁcitfor14weeks
(5). The remaining postmenopausal
women were randomized to either 6
months of aerobic exercise (n  16) per-
formed 5 times per week got 30 min or to
resistance and aerobic exercise combined
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min of aerobic exercise plus 20 min of
resistance exercise per session) (6).
Anthropometric, metabolic, and
magnetic resonance imaging
measurements
Allanthropometricandwhole-bodymag-
netic resonance imaging data were ob-
tained using standard procedures (4–6).
Blood samples used to determine fasting
glucose, insulin, lipid, and lipoprotein
values were obtained in the morning after
a 12- to 14-h fast. The hyperinsulinemic
euglycemic clamp procedure used to de-
termineinsulinsensitivitywasidenticalin
all studies (4–6).
Statistical analyses
Baseline differences for all variables be-
tween groups were assessed using a
2-by-2 (sex-by-metabolic stratiﬁcation)
ANCOVAwithageasacovariate.Posthoc
analysis was performed using indepen-
dent-samples t tests with a Bonferroni
correction for multiple comparisons.
Changes in variables (prepost) in re-
sponse to intervention were assessed us-
ingrepeated-measuresANCOVAwithsex
and metabolic stratiﬁcation as the be-
tween-subjects factors with inclusion of
age and treatment modality as covariates.
Subsequentcomparisonswereperformed
with a Bonferroni correction for multiple
comparisons. Statistical procedures were
performed using SPSS 17.0 software
(Chicago, IL).
RESULTS— Subject characteristics
and the effects of intervention among
MAO and MHO are in Table 1. With the
exception of skeletal muscle, all anthro-
pometric and adipose tissue measures re-
duced signiﬁcantly in response to
intervention among MAO and MHO men
andwomen(P0.05).Insulinsensitivity
increased in both MAO and MHO groups
independent of sex (P  0.05); the
change was greater in the MAO groups
(P0.05).Improvementsinselectedcar-
dio-metabolic risk factors also occurred
inbothMAOandMHOmenandwomen,
but were more common in the MAO
groups.
CONCLUSIONS — It has been re-
ported that a modest weight reduction
achieved via caloric restriction resulted in
a 13% deterioration in insulin sensitivity
among a group of postmenopausal MHO
women (2). Our results counter these ob-
servations as insulin sensitivity improved
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18.5%,respectively,regardlessofweight-
loss modality (these data can be found
insupplementaryFig.2,availableinthe
online appendix). This experimental
ﬁnding is consistent with recent obser-
vational studies wherein MHO and
MAO individuals were at similarly ele-
vated risk of cardiovascular disease
and all-cause mortality in comparison
to metabolically healthy and lean
individuals (8,9). Additionally, in com-
parison to metabolically healthy lean
adults, MHO individuals showed signs
of subclinical vascular disease marked
by a signiﬁcantly greater intima-media
thickness of the common carotid artery
and endothelial dysfunction (10).
While limited health care resources
dictate the need to prioritize high-risk
obese individuals for aggressive treat-
ment, the notion that individuals with
uncomplicated obesity would not ben-
eﬁt from lifestyle-induced weight loss
seems an inappropriate public health
message. This message may be particu-
larlymisguidedatatimewhentheprev-
alence of obesity and its attendant
diseases continues to increase despite a
greater public awareness of the beneﬁts
ofweightloss(11).Indeed,ourﬁndings
reinforce the recommendation that
weight or waist circumference reduc-
tion in response to lifestyle-based treat-
mentstrategiesshouldbeconsideredan
appropriate treatment option for all
obese men and women regardless of
current metabolic status.
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